Human SUMO Specific Peptidase 2 (SENP2) Protein
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Human Sentrin-Specific Protease 2 Protein is a recombinant protein from Human produced in E. coli. Recombinant Human Sentrin-specific protease 2 is produced by our E.coli expression system and the target gene encoding Asp363-Leu589 is expressed.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Sentrin-Specific Protease 2 |
| Host | E. coli |
| Origin | Human |
| Observed MW | Molecular Weight: 26.8 kDa Sequence Fragment: Asp363-Leu589 Tag: N-terminal 6 His tag Validity: The validity for this protein is 6 months. |
| Expression | Recombinant |
| Purity | > 95% (SDS-PAGE) |
| Size 1 | 10 µg |
| Size 2 | 50 µg |
| Tested Applications | SDS-PAGE |
| Buffer | 50mM HEPES, 5% Glycerol, pH 7.4. |
| Availability | Shipped within 5-15 working days. |
| Storage | Aliquot and store at < -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q9HC62 |
| Background | Protein SENP2 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
Recombinant Human SENP2
Ver Producto
SUMO Specific Peptidase 2 (SENP2) Antibody
SUMO is a small ubiquitin-like protein that can be covalently conjugated to other proteins. SENP2 is one of a group of enzymes that process newly synthesized SUMO1, SUMO2, and SUMO3 into the conjugatable mature forms and catalyze the deconjugation of these same SUMO proteins from their targeted substrates. SENP2 may also down-regulate CTNNB1 levels and thereby modulate the Wnt pathway.
Ver Producto
SUMO Specific Peptidase 2 (SENP2) Antibody
SUMO is a small ubiquitin-like protein that can be covalently conjugated to other proteins. SENP2 is one of a group of enzymes that process newly synthesized SUMO1, SUMO2, and SUMO3 into the conjugatable mature forms and catalyze the deconjugation of these same SUMO proteins from their targeted substrates. SENP2 may also down-regulate CTNNB1 levels and thereby modulate the Wnt pathway.
Ver Producto